Walgreens Anticavity and Antigingivitis Whitening

Description

The product associated with SPL Code 34089-3 does not have specific description details provided in the available data. Further information regarding its chemical composition, molecular weight, dosage form, or appearance is not available for inclusion.

Uses and Indications

This drug is indicated for the protection against dental cavities. It is designed to support oral health by reducing the risk of cavity formation in patients.

Dosage and Administration

Adults and children aged 6 years or older are advised to brush their teeth thoroughly, preferably after each meal, or at least twice daily, or as directed by a dentist. It is important to ensure that the product is not swallowed during the brushing process.

For children between the ages of 6 and 12 years, a pea-sized amount of the product should be used to minimize the risk of swallowing. Caregivers should supervise the brushing process until proper oral hygiene habits are established.

For children under the age of 6 years, it is recommended to consult a dentist or physician for appropriate guidance on the use of the product.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

It is imperative to keep fluoride toothpaste out of the reach of children under 6 years of age. Accidental ingestion of amounts greater than what is typically used for brushing can pose serious health risks. In such cases, it is crucial to seek professional medical assistance or contact the Poison Control Center immediately to ensure appropriate management and care.

Healthcare professionals should remain vigilant regarding the potential for fluoride toxicity in young children and educate caregivers on the importance of supervising the use of fluoride toothpaste. Proper storage and usage guidelines should be emphasized to mitigate the risk of accidental ingestion.

Side Effects

Patients should be aware of the potential risks associated with the use of this product. It is crucial to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of an amount greater than that used for brushing, it is imperative to seek professional help or contact the Poison Control Center immediately.

While specific adverse reactions were not detailed in clinical trials or postmarketing experiences, the importance of adhering to safety guidelines cannot be overstated to prevent serious outcomes.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Anticavity and Antigingivitis Whitening (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using fluoride toothpaste. It is recommended to keep fluoride toothpaste out of reach of children under 6 years of age. For children aged 6 to 12 years, a pea-sized amount of toothpaste should be used to minimize the risk of swallowing, and caregivers should supervise brushing until proper oral hygiene habits are established. For children under 6 years, consultation with a dentist or physician is advised prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be informed of the absence of established safety data during pregnancy.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for Walgreens Anticavity and Antigingivitis Whitening Sodium Fluoride Paste, Dentifrice. Therefore, healthcare professionals should exercise caution and consider the potential risks and benefits when recommending this product to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If a patient accidentally ingests more than the recommended amount used for brushing, it is crucial to seek professional assistance without delay.

Healthcare providers should advise the patient or caregiver to contact the Poison Control Center immediately for guidance on the appropriate steps to take. Prompt intervention is essential to mitigate potential adverse effects associated with overdosage.

Monitoring for symptoms related to overdosage is also important, although specific symptoms are not detailed in the provided information. Therefore, healthcare professionals should remain vigilant and assess the patient for any unusual signs or reactions following an overdosage incident.

In summary, immediate professional help and contact with the Poison Control Center are the recommended actions in the case of overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young children. Providers should emphasize the necessity of storing the medication in a secure location, away from children's sight and reach, to ensure safety.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature to maintain its efficacy. It is imperative to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. Additionally, users are advised not to swallow the product.

Additional Clinical Information

The product is administered via the dental route. For adults and children aged 6 years and older, it is recommended to brush teeth thoroughly, preferably after each meal or at least twice daily, or as directed by a dentist. Patients should avoid swallowing the product. For children aged 6 to 12 years, a pea-sized amount should be used to minimize swallowing, and brushing should be supervised until proper habits are established. For children under 6 years, consultation with a dentist or physician is advised.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Walgreens Anticavity and Antigingivitis Whitening, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)